solid tumors
| 2 min read
The new investment accelerates development of a potential breakthrough therapy targeting the one-carbon metabolic pathway.
| 4 min read
Early clinical trials show that a KRAS G12D inhibitor can shrink tumors in patients with advanced pancreatic and other solid cancers.
| 6 min read
ArsenalBio equips T cells with multiple weapons to identify, attack, and persist against tumors, bringing the power of CAR T cell technology to solid cancers.
Page 1 of 1 - 3 Total Items
